Aether Industries Q1 FY27 Share Price & Earnings Call Analysis

₹1,581.00-0.47% today
Market cap
₹20,979 Cr
P/E
87.42
ROE
9.66%
PEG
4.30
Price to sales
17.04
Debt to equity
0.19
52W high / low
₹1,800 / ₹733
EBITDA margin
31.34%
Net profit margin
19.50%
Promoter holding
74.92%
Sales (last year)
₹1,231 Cr

Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]

Guidance scorecard · Q1 FY27 call

What Aether Industries Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#17of 71 in
Chemicals & Petrochemicals

RevenueQ1 FY27 call

20–40%
  • CEM (Contract Exclusive Manufacturing) and CRAMS (Contract Research and Manufacturing Services) are expected to contribute over 70% of revenue in the next couple of years, indicating strong growth in these high-margin segments.
  • Site 3++ block ramp-up and Site 5 commissioning are on schedule, which will increase production capacity and sales in upcoming quarters.
  • New customer onboarding and more than nine customer audits cleared in Q1 FY27 signal a strong and growing order pipeline.
  • Organic growth in the oil and gas segment, which already accounts for around 20% of revenue and expected to increase further.
  • Semiconductor and material science segments have high growth potential with multiyear R&D programs underway, including new product commercialization starting Q2 FY27.

2 more points from Aether Industries Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Aether Industries Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Total capex for Q1 FY27 was INR 943 million.
  • Capex expected for FY27 is between INR 3,000 million to INR 3,500 million.
  • FY27 capex primarily allocated to Site 5 and the new R&D site, which is progressing well.
  • Expansion includes Site 3++ ramp-up and capacity scaling at Site 5.
  • Strategic investments include building manufacturing capacity near Surat at Panoli (Magnum Site 5).
  • Focus on concurrent expansions in R&D, pilot plants, and manufacturing assets.

2 more points from Aether Industries Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Aether Industries Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Rising
  • Commercial sales for new LSM products at Site 5 started in Q1 FY27, with revenue contribution expected from Q2 FY27.
  • Order buildup is in progress for new LSM products across pharmaceutical, agrochemical, and material science sectors.
  • The CEM and CRAMS pipelines are described as the deepest ever, with strong order visibility and rising urgency from Western customers in FY27.
Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track Aether Industries Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Aether Industries Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Aether Industries Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +184161164155118180199220240256280319305
Expenses +124116118124107137145155161175192207222
Operating Profit604546311043546580818811283
OPM %32%28%28%20%9%24%27%29%33%32%31%35%27%
Other Income +12145498112-06-410
Interest1122432355346
Depreciation791010101011111314171718
Profit before tax5237492403949616462748768
Tax %28%19%25%27%486%24%28%29%21%24%27%26%21%
Net Profit +38303717-13035435047546454
EPS in Rs3.022.252.771.31-0.112.262.633.273.793.554.074.864.07

Financials of Aether Industries Ltd

Profit & Loss

Annual income statement trend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5906515988391,160
Expenses +422465466598796
Operating Profit168186132241364
OPM %28%29%22%29%31%
Other Income +717253012
Interest13591318
Depreciation1523404566
Profit before tax146174110213291
Tax %26%25%25%26%25%
Net Profit +10913082158219
EPS in Rs9.6710.476.2211.9516.54
Dividend Payout %0%0%0%0%0%

Financials of Aether Industries Ltd

Balance Sheet

Capital structure and asset base

Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital113125133133133
Reserves2741,1201,9312,0932,196
Borrowings +29116183200215
Other Liabilities +92120154218306
Total Liabilities7701,3802,4012,6442,849
Fixed Assets +2576468531,1171,196
CWIP5837232363556
Investments171000
Other Assets +4386951,3151,1631,096
Total Assets7701,3802,4012,6442,849

Financials of Aether Industries Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-5-7-16100142
Cash from Investing Activity +-151-348-424-418-619
Cash from Financing Activity +1694398942244
Net Cash Flow1284453-316-233
Free Cash Flow-157-363-444-352-390
CFO/OP17%14%1%57%54%

Financials of Aether Industries Ltd

Ratios

Working capital efficiency and return ratios

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days101145142126
Inventory Days221301411356
Days Payable9599124114
Cash Conversion Cycle227348429367
Working Capital Days82268279238
ROCE %18%7%10%

Guidance history

How Aether Industries Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatPlanned—Rising
Q4 FY26 call →20–40%FlatPlannedPlannedRising
Q3 FY26 call →20–40%FlatPlanned——
Q2 FY26 call →20–40%FlatPlannedPlannedRising

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

85out of 100

Momentum score · price trend

85 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+110.8%94%
Last 6 months+34.9%83%
Last 3 months+6.1%74%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Aether Industries Ltd: 0.4 × 94 + 0.4 × 83 + 0.2 × 74 = 85.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.